Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel transcript, antisense to cytochrome P450 2E1 (ENSG00000278518)
- Target
- ENSG00000278518
- Molecular classification
- Long non-coding RNA (lncRNA), Natural antisense transcript
01
Overview
Novel transcript, antisense to cytochrome P450 2E1 (ENSG00000278518) is a long non-coding RNA transcribed in the opposite direction of the CYP2E1 gene. Natural antisense transcripts (NATs) can regulate their sense counterparts by diverse mechanisms, including modulation of transcription, chromatin structure, and transcript stability[9][1]. For CYP2E1, antisense transcription at its locus is believed to influence the regulation of CYP2E1’s sense transcript dynamics, potentially by altering chromatin architecture and transcription processing at the locus[1]. There is no evidence to date that this antisense RNA is involved in disease mechanisms or is a target of therapeutic agents. Its biological relevance may relate primarily to fine-tuning gene regulation in the region of CYP2E1.
- Other names
- antisense to CYP2E1CYP2E1-AS (not widely used; included for search purposes)
02
Mechanism of action
Drugs do not target this molecule directly.
03
Biological functions
Regulation of gene expression (via antisense interaction with CYP2E1)Epigenetic modulation (potentially alters chromatin environment and regulation of transcription at the CYP2E1 locus)
04
Disease associations
Other (“Gene regulation” and “chromatin modification” may indirectly impact disease, but there’s no established direct role)
Beyond the preview
Go deeper on Novel transcript, antisense to cytochrome P450 2E1 (ENSG00000278518).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novel transcript, antisense to cytochrome P450 2E1 (ENSG00000278518).